Coronavirus crisis shines a light on small-cap pharma groups like Scancell
As global efforts to tackle the pandemic intensify, so the spotlight has finally shifted to focus on the potential of small pharma players during the week beginning 27th April. According to Ivan Sedgwick, a director at corporate finance firm LGB & Co, the poor share price performance of major healthcare names has demoralised investors, forcing … Read more